What is the size and duration of Cosmos Health's new share repurchase program?

The Board authorized a $5 million share repurchase program effective through December 31, 2026. According to CEO Greg Siokas, this amount represents almost half of the company's market capitalization as of June 29, 2026.

Why is Cosmos Health launching this repurchase program now?

CEO Siokas cited confidence in the company's operating fundamentals and growth prospects, including record revenue, improving margins, and accelerating global expansion into the United States and new categories such as animal healthcare. The company believes its shares are undervalued relative to its growth trajectory.

Is Cosmos Health obligated to repurchase the full $5 million in shares?

No. The program is discretionary and the company may adjust timing and amounts based on business conditions, prevailing stock prices, and corporate priorities. There is no obligation to execute any repurchases.

Can Cosmos Health extend or modify this authorization after December 31, 2026?

Yes. The program expires on December 31, 2026, but may be renewed at the Company's sole discretion. Management can adjust or discontinue the program at any time.

COSM 8-K Filed 2026-07-06 New authorization

Cosmos Health authorizes $5M share repurchase program

Board approves buyback initiative expiring December 31, 2026, as company cites confidence in operating fundamentals and growth prospects.

Authorization$5M

MechanismRule 10b5-1 and 10b-18 open-ma

What the filing says

Cosmos Health Inc. (NASDAQ: COSM) announced that its Board of Directors has authorized a share repurchase program of up to $5 million of the Company's common stock, effective through December 31, 2026. The company may repurchase shares through open-market purchases, privately negotiated transactions, or other permitted means in accordance with SEC Rules 10b5-1 and 10b-18.

The timing and total amount of repurchases will depend on market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. CEO Greg Siokas stated that the authorization reflects confidence in the company's operating fundamentals and growth prospects, including record revenue, improving margins, and expanding global momentum into the United States and new categories such as animal healthcare. Siokas noted that a program of this size represents almost half of the company's market capitalization as of June 29, 2026.

The repurchase program may be renewed at the Company's sole discretion and has an expiration date of December 31, 2026.

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its Board of Directors has authorized a share repurchase program of up to $5 million of the Company's common stock. — Cosmos Health Inc. 8-K filing · View on SEC EDGAR →

What this means

Cosmos Health has authorized a $5 million share repurchase program expiring December 31, 2026. According to the company's CEO, this authorization represents approximately half of the company's market capitalization as of the announcement date. The program provides flexibility to execute purchases through standard open-market mechanisms and privately negotiated transactions, subject to SEC Rule compliance and market conditions. The repurchase authorization does not obligate the company to purchase any shares and may be renewed or terminated at management's discretion.

Frequently asked questions

What is the size and duration of Cosmos Health's new share repurchase program?: The Board authorized a $5 million share repurchase program effective through December 31, 2026. According to CEO Greg Siokas, this amount represents almost half of the company's market capitalization as of June 29, 2026.
How will Cosmos Health execute this repurchase program?: The company may repurchase shares through open-market purchases, privately negotiated transactions, or other permitted means in accordance with SEC Rules 10b5-1 and 10b-18. Timing and total amount will depend on market conditions, stock prices, and regulatory requirements.
Why is Cosmos Health launching this repurchase program now?: CEO Siokas cited confidence in the company's operating fundamentals and growth prospects, including record revenue, improving margins, and accelerating global expansion into the United States and new categories such as animal healthcare. The company believes its shares are undervalued relative to its growth trajectory.
Is Cosmos Health obligated to repurchase the full $5 million in shares?: No. The program is discretionary and the company may adjust timing and amounts based on business conditions, prevailing stock prices, and corporate priorities. There is no obligation to execute any repurchases.
Can Cosmos Health extend or modify this authorization after December 31, 2026?: Yes. The program expires on December 31, 2026, but may be renewed at the Company's sole discretion. Management can adjust or discontinue the program at any time.

authorization small-cap healthcare-sector rule-10b-18 open-market

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.